The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Fake Hermès Birkin bags and other counterfeit luxury goods are popular not only with people on a budget, but also with those with deeper pockets, a new study suggests.
Researchers from the National University of Singapore analyzed millions of counterfeit purchases by American consumers from more than 24,000 U.S. zip codes on a major cross-border, e-commerce platform. They found that both lower- and higher-income individuals are “significantly more likely” to buy fake luxury items than middle-income consumers, according to a press release by INFORMS on Monday.
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates and was associated with significantly lower mortality, according to new research published in the INFORMS journal Manufacturing & Service Operations Management.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
There aren’t enough chips to go around. The ongoing global semiconductor shortagemeans the difficulty of buying a PlayStation 5, Xbox Series X, or high-end GPU from companies like Nvidia or AMD could go on for months — if not for the rest of 2021.
The 2020 LinkedIn U.S. Emerging Jobs Reportidentified the top 15 jobs over the previous five years and emphasized that “artificial intelligence and data science roles continue to proliferate across nearly every industry.” Artificial intelligence specialist (No. 1) showed 74% annual growth, and data scientist (No. 3) and data engineer (No. 8) followed with 37% and 33% annual growth.
Walgreens has inoculated hundreds of thousands of Americans against COVID-19 this year using the vaccine developed by Pfizer and Germany’s BioNTech. But the pharmacy chain has not been following guidance from federal health officials about the timing of second doses.
DETROIT — After a year of getting hammered by the pandemic, a semiconductor shortage and storms that snarled Dana Inc.’s global supply chain, the supplier is reaching for a new playbook.
On Wednesday, Johnson & Johnson acknowledged that a huge batch of vaccines—enough for 15 million doses—had to be tossed out after it was found to have been contaminated during the production process. Soon afterward, several outlets reported that the company producing the vaccine at that Baltimore facility, Emergent BioSolutions, had been cited multiple times before for quality control issues. The sheer number of doses that were discarded, and the idea of a “contamination” of a COVID vaccine, has raised plenty of questions.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine